Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
Clinical trial NCT01940991 · COMPLETED
Trial details
- NCT number
- NCT01940991
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2013-11-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.